Report / Trial registry metadata
Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure
This study concerns ARDS (Acute Respiratory Distress Syndrome), Acute Hypoxic Respiratory Failure. Its registered status is not yet recruiting. The planned measures below describe the study design, not demonstrated treatment effects.
What is being studied?
- Conditions
- ARDS (Acute Respiratory Distress Syndrome), Acute Hypoxic Respiratory Failure
- Study type
- Interventional
- Purpose
- Treatment
- Phase
- PHASE2
How is the study designed?
- Enrollment
- 300 (estimated)
- Group design
- Parallel
- Allocation
- Randomized
- Masking
- None
- Minimum age
- 18 Years
- Eligibility sex
- All
Which interventions are listed?
- Drug: Simvastatin
- Drug: Baricitinib
What will the study measure?
- 28 day organ support free days Assessment window: in- hospital through day 28
What can this record establish?
These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.
- Kind
- Trial registry metadata
- Identifier
- NCT07779642
- Status
- NOT_YET_RECRUITING